Schedule 13G ownership disclosure
Madrigal Pharmaceuticals Inc
Security class unavailable · CUSIP: 558868105
Event date: 2018-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,664,452
- Percent of class
- 10.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-18-000399
- Form type
- SC 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Aug 10, 2018
- Reporting period
- Jul 31, 2018
- Description
- Schedule 13G beneficial ownership